COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR
Video Credit: ANI - Duration: 02:24s - Published
COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR
Director General of Indian Council of Medical Research, Dr Balram Bhargava on August 04 stated that Oxford vaccine, being manufactured by Serum Institute of India, got approval for phase 2 and 3 clinical trials which are starting within a week at 17 sites.
Earlier, the Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford vaccine.
India crossed 36 lakh mark of coronavirus cases including 7,81,975 active cases on Aug 31. The spike of 78,512 new cases and 971 deaths reported in India in last 24 hours. With 971 deaths, cumulative..
Country on August 28 reported steepest single-day spike of 77,266 coronavirus cases in the last 24 hours, the data released by the Ministry of Health and Family Welfare showed. 1,057 deaths in the last..
Rhea charged under NDPS Act for ‘links to banned drugs’. Oppn joins hands against govt over NEET-JEE. Phase II human trial of Oxford vaccine begins in India. And NBA team takes stand on racism,..
Credit: HT Digital Content Duration: 05:41Published
![India's COVID tally crosses 36 lakh mark [Video]](https://video.newsserve.net/300/v/20200831/2008310913-India-COVID-tally-crosses-36-lakh-mark.jpg)
![India reports record 77,266 coronavirus cases in 24 hours [Video]](https://video.newsserve.net/300/v/20200828/2008280903-India-reports-record-77-266-coronavirus-cases-in.jpg)
![EJ Espresso: Rhea charged under NDPS Act; NBA team takes stand on racism [Video]](https://video.newsserve.net/300/v/20200827/2008270757-EJ-Espresso-Rhea-charged-under-NDPS-Act-NBA.jpg)
